|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2000-8-17
|
|
pubmed:abstractText |
We have tried to establish short-term cultures of autologous tumors from patients with renal cell carcinoma that could be used as active specific immunotherapy (i.e., autologous vaccine) in such patients after resection of primary kidney cancer, and/or for the treatment of metastatic cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1084-9785
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
161-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10803321-Bone Neoplasms,
pubmed-meshheading:10803321-Cancer Vaccines,
pubmed-meshheading:10803321-Carcinoma, Renal Cell,
pubmed-meshheading:10803321-Cell Culture Techniques,
pubmed-meshheading:10803321-Combined Modality Therapy,
pubmed-meshheading:10803321-Humans,
pubmed-meshheading:10803321-Immunotherapy, Active,
pubmed-meshheading:10803321-Kidney Neoplasms,
pubmed-meshheading:10803321-Nephrectomy,
pubmed-meshheading:10803321-Tumor Cells, Cultured
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Short-term tumor cell lines from renal cell carcinoma for use as autologous tumor cell vaccines in the treatment of kidney cancer.
|
|
pubmed:affiliation |
Hoag Cancer Center, Newport Beach, California 92658, USA. rdillman@hoaghospital.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
